Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country

Although BRCA1/2 genetic testing in developed countries is part of the reality for high-risk patients for hereditary breast and ovarian cancer (HBOC), the same is not true for upper-middle-income countries. For that reason, this study aimed to evaluate whether the BRCA1/2 genetic test and preventive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenção, Marina, Simões Correa Galendi, Julia, Galvão, Henrique de Campos Reis, Antoniazzi, Augusto Perazzolo, Grasel, Rebeca Silveira, Carvalho, André Lopes, Mauad, Edmundo Carvalho, de Oliveira, Jorge Henrique Caldeira, Reis, Rui Manuel, Mandrik, Olena, Palmero, Edenir Inêz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309566/
https://www.ncbi.nlm.nih.gov/pubmed/35898894
http://dx.doi.org/10.3389/fonc.2022.951310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309566/
https://www.ncbi.nlm.nih.gov/pubmed/35898894
http://dx.doi.org/10.3389/fonc.2022.951310

Ejemplares similares